STOCK TITAN

Dss Inc Financials

DSS
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Dss Inc (DSS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DSS FY2025

Loss reduction came mainly from a fixed-cost reset, while the balance sheet grew more strained than the income statement suggests.

From FY2024 to FY2025, operating margin improved from -223.1% to -69.5%, showing the cost base was cut much faster than the revenue line changed. Yet operating cash flow still ran at -$9.1M while equity slipped below zero to -$832K, so the cleaner income statement did not translate into a self-funding balance sheet.

The biggest visible lever was overhead compression: SG&A fell to $12.3M in FY2025 from $38.2M in FY2024. That means the narrower loss mostly reflects a smaller corporate cost structure, while still-negative cash flow shows the core operation has not yet become cash generative.

The balance-sheet cushion has thinned as total assets shrank sharply over the last two years while liabilities stayed comparatively sticky. A current ratio of 0.3x with only $6.2M of cash indicates the business is leaning more on asset sales, financing actions, or liability management than on internally generated cash to handle near-term claims.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 44 / 100
Financial Health Score 44/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Dss Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
34
Dilution
97
R&D Intensity
8
Revenue Progress
33
Burn Trend
70
Balance Sheet
24
Altman Z-Score Distress
-7.70

Dss Inc scores -7.70, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($5.6M) relative to total liabilities ($58.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Dss Inc passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.38x

For every $1 of reported earnings, Dss Inc generates $0.38 in operating cash flow (-$9.1M OCF vs -$23.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-54.3x

Dss Inc earns $-54.3 in operating income for every $1 of interest expense (-$14.4M vs $266K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$20.8M
YoY+8.7%
5Y CAGR+6.2%
10Y CAGR+1.7%

Dss Inc generated $20.8M in revenue in fiscal year 2025. This represents an increase of 8.7% from the prior year.

EBITDA
-$11.5M
YoY+71.4%

Dss Inc's EBITDA was -$11.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 71.4% from the prior year.

Net Income
-$23.9M
YoY+49.0%

Dss Inc reported -$23.9M in net income in fiscal year 2025. This represents an increase of 49.0% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$6.2M
YoY-45.6%
5Y CAGR+3.7%
10Y CAGR+15.7%

Dss Inc held $6.2M in cash against $5.7M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
9M
YoY+12.4%

Dss Inc had 9M shares outstanding in fiscal year 2025. This represents an increase of 12.4% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
-69.5%
YoY+153.5pp
5Y CAGR+4.8pp
10Y CAGR+10.9pp

Dss Inc's operating margin was -69.5% in fiscal year 2025, reflecting core business profitability. This is up 153.5 percentage points from the prior year.

Net Margin
-115.3%
YoY+130.3pp
5Y CAGR-127.6pp
10Y CAGR-33.5pp

Dss Inc's net profit margin was -115.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 130.3 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
$340K
YoY+22.3%
5Y CAGR+10.1%
10Y CAGR-3.2%

Dss Inc invested $340K in research and development in fiscal year 2025. This represents an increase of 22.3% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

DSS Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $4.3M+5.0% $4.1M-35.5% $6.4M+20.9% $5.3M+6.7% $5.0M-8.5% $5.4M-3.3% $5.6M+33.0% $4.2M
Cost of Revenue $4.4M N/A N/A N/A N/A N/A N/A N/A
Gross Profit -$276K N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $4.3M+113.9% $2.0M-43.7% $3.6M+10.8% $3.2M-8.1% $3.5M-87.3% $27.5M+648.7% $3.7M+5.6% $3.5M
Operating Income -$5.5M-35.5% -$4.0M-25.2% -$3.2M+5.6% -$3.4M+8.1% -$3.7M+86.8% -$28.3M-506.1% -$4.7M+5.3% -$4.9M
Interest Expense $39K-45.8% $72K+89.5% $38K-69.1% $123K+272.7% $33K-17.5% $40K-24.5% $53K-62.7% $142K
Income Tax -$67K N/A N/A N/A -$67K N/A N/A -$188K
Net Income -$5.8M+59.4% -$14.3M-542.3% -$2.2M+14.5% -$2.6M+45.4% -$4.8M+85.5% -$32.9M-522.0% -$5.3M-12.8% -$4.7M
EPS (Diluted) N/A N/A N/A N/A N/A N/A $-0.75-13.6% $-0.66

DSS Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $71.3M+5.4% $67.6M-26.6% $92.1M-1.4% $93.4M+1.0% $92.4M-13.2% $106.5M-25.4% $142.7M-1.2% $144.4M
Current Assets $10.7M-25.5% $14.3M-16.1% $17.1M-9.4% $18.9M-64.3% $52.8M-20.8% $66.7M-3.1% $68.8M+1.6% $67.7M
Cash & Equivalents $4.9M-20.6% $6.2M-11.5% $7.0M-25.2% $9.4M-13.4% $10.8M-5.2% $11.4M-1.7% $11.6M+8.5% $10.7M
Inventory $1.8M-9.0% $2.0M-30.4% $2.9M+12.9% $2.5M+1.8% $2.5M+2.3% $2.4M-26.2% $3.3M-7.4% $3.6M
Accounts Receivable $2.0M-9.4% $2.3M-45.5% $4.1M+54.0% $2.7M+2.3% $2.6M-14.4% $3.1M+15.6% $2.7M+4.8% $2.5M
Goodwill $1.8M0.0% $1.8M0.0% $1.8M0.0% $1.8M0.0% $1.8M0.0% $1.8M-93.4% $26.9M0.0% $26.9M
Total Liabilities $58.7M-0.3% $58.9M-10.8% $66.0M0.0% $66.0M+5.4% $62.6M-15.1% $73.7M+1.0% $73.0M-18.3% $89.3M
Current Liabilities $47.7M+0.4% $47.5M-12.4% $54.2M+0.7% $53.8M-0.4% $54.0M-16.9% $65.0M+10.1% $59.1M+2.5% $57.7M
Long-Term Debt $5.5M-4.0% $5.7M-4.1% $6.0M-3.3% $6.2M+157.4% $2.4M0.0% $2.4M-67.8% $7.4M+5.9% $7.0M
Total Equity $3.4M+505.6% -$832K-105.9% $14.2M-9.4% $15.7M-12.3% $17.9M-10.4% $19.9M-61.7% $52.1M-5.5% $55.2M
Retained Earnings -$332.8M-1.8% -$327.0M-4.7% -$312.3M-0.7% -$310.0M-0.7% -$307.8M-1.6% -$303.1M-12.2% -$270.2M-2.0% -$264.9M

DSS Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$133K+91.4% -$1.6M+80.6% -$8.0M-3155.7% $262K+56.0% $168K+105.8% -$2.9M-811.7% -$315K+90.8% -$3.4M
Capital Expenditures $4.6M N/A $82K-10.9% $92K+76.9% $52K-50.0% $104K $0-100.0% $26K
Free Cash Flow -$4.8M N/A -$8.1M-4857.6% $170K+46.6% $116K+103.9% -$3.0M-844.8% -$315K+90.9% -$3.5M
Investing Cash Flow -$2.6M-144.0% $6.0M+208.0% $1.9M+308.0% -$935K-108.4% $11.1M+398.2% $2.2M+94.9% $1.1M-69.0% $3.7M
Financing Cash Flow $1.4M+126.6% -$5.2M-241.9% $3.7M+551.8% -$818K+93.0% -$11.7M-2698.7% $450K+417.2% $87K-92.8% $1.2M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

DSS Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin -6.7% N/A N/A N/A N/A N/A N/A N/A
Operating Margin -126.7%-28.6pp -98.1%-47.5pp -50.6%+14.2pp -64.8%+10.4pp -75.2%+447.5pp -522.7%-439.3pp -83.4%+33.8pp -117.2%
Net Margin -134.4%+212.6pp -347.0%-312.1pp -34.9%+14.5pp -49.3%+47.1pp -96.4%+510.3pp -606.7%-512.3pp -94.4%+16.9pp -111.2%
Return on Equity -172.4% N/A -15.7%+0.9pp -16.6%+10.1pp -26.7%+138.0pp -164.8%-154.6pp -10.1%-1.7pp -8.5%
Return on Assets -8.2%+13.0pp -21.2%-18.8pp -2.4%+0.4pp -2.8%+2.4pp -5.2%+25.7pp -30.9%-27.2pp -3.7%-0.5pp -3.2%
Current Ratio 0.22-0.1 0.30-0.0 0.32-0.0 0.35-0.6 0.98-0.0 1.03-0.1 1.160.0 1.17
Debt-to-Equity 1.63 N/A 0.42+0.0 0.39+0.3 0.13+0.0 0.12-0.0 0.14+0.0 0.13
FCF Margin -115.1% N/A -126.5%-129.8pp 3.2%+0.9pp 2.3%+57.3pp -54.9%-49.3pp -5.6%+76.3pp -81.9%

Note: Shareholder equity is negative (-$832K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.30), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Dss Inc (DSS) reported $20.8M in total revenue for fiscal year 2025. This represents a 8.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Dss Inc (DSS) revenue grew by 8.7% year-over-year, from $19.1M to $20.8M in fiscal year 2025.

No, Dss Inc (DSS) reported a net income of -$23.9M in fiscal year 2025, with a net profit margin of -115.3%.

Dss Inc (DSS) had EBITDA of -$11.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Dss Inc (DSS) had $6.2M in cash and equivalents against $5.7M in long-term debt.

Dss Inc (DSS) had an operating margin of -69.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Dss Inc (DSS) had a net profit margin of -115.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Dss Inc (DSS) generated -$9.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Dss Inc (DSS) had $67.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Dss Inc (DSS) invested $340K in research and development during fiscal year 2025.

Dss Inc (DSS) had 9M shares outstanding as of fiscal year 2025.

Dss Inc (DSS) had a current ratio of 0.30 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Dss Inc (DSS) had a return on assets of -35.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Dss Inc (DSS) had $6.2M in cash against an annual operating cash burn of $9.1M. This gives an estimated cash runway of approximately 8 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Dss Inc (DSS) has negative shareholder equity of -$832K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Dss Inc (DSS) has an Altman Z-Score of -7.70, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Dss Inc (DSS) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Dss Inc (DSS) has an earnings quality ratio of 0.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Dss Inc (DSS) has an interest coverage ratio of -54.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Dss Inc (DSS) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top